Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111507496 | 11150749 | 6 | F | 2015 | 20160920 | 20150601 | 20160922 | EXP | CA-ROCHE-1518882 | ROCHE | 56.33 | YR | F | Y | 0.00000 | 20160922 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111507496 | 11150749 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 640 | MG | SOLUTION FOR INFUSION | ||||||||
| 111507496 | 11150749 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | SOLUTION FOR INFUSION | ||||||||||
| 111507496 | 11150749 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | SOLUTION FOR INFUSION | ||||||||||
| 111507496 | 11150749 | 4 | SS | ORENCIA | ABATACEPT | 1 | Unknown | U | 0 | ||||||||||
| 111507496 | 11150749 | 5 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAY 1 15 | U | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 111507496 | 11150749 | 6 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
| 111507496 | 11150749 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 111507496 | 11150749 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 111507496 | 11150749 | 9 | C | NAPROXEN. | NAPROXEN | 1 | 0 | ||||||||||||
| 111507496 | 11150749 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 111507496 | 11150749 | 11 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 111507496 | 11150749 | 12 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
| 111507496 | 11150749 | 13 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 111507496 | 11150749 | 14 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111507496 | 11150749 | 1 | Rheumatoid arthritis |
| 111507496 | 11150749 | 4 | Product used for unknown indication |
| 111507496 | 11150749 | 5 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111507496 | 11150749 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111507496 | 11150749 | Abdominal pain | |
| 111507496 | 11150749 | Arthralgia | |
| 111507496 | 11150749 | Blood pressure increased | |
| 111507496 | 11150749 | Diverticulitis | |
| 111507496 | 11150749 | Drug ineffective | |
| 111507496 | 11150749 | Feeling hot | |
| 111507496 | 11150749 | Haemorrhage | |
| 111507496 | 11150749 | Head discomfort | |
| 111507496 | 11150749 | Headache | |
| 111507496 | 11150749 | Infusion related reaction | |
| 111507496 | 11150749 | Pruritus | |
| 111507496 | 11150749 | Rheumatoid arthritis | |
| 111507496 | 11150749 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111507496 | 11150749 | 1 | 20141211 | 20150427 | 0 | |
| 111507496 | 11150749 | 2 | 20150107 | 0 | ||
| 111507496 | 11150749 | 3 | 20150202 | 20150427 | 0 | |
| 111507496 | 11150749 | 5 | 20150708 | 0 | ||
| 111507496 | 11150749 | 6 | 20150708 | 0 | ||
| 111507496 | 11150749 | 13 | 20150708 | 0 | ||
| 111507496 | 11150749 | 14 | 20150708 | 0 |